← Back

ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.

Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. researches, develops, produces, and sells disposable sterile infusion medical devices in China. Its products include safety hypodermic needles, safety blood collection needles and sets, conventional syringes, hypodermic and blood collection needles, insulin syringes and pen needles, as well as infusion, blood administration, burette, and scalp vein sets. The company also exports to approximately 80 countries. Founded in 2011, it is headquartered in Anqing, China.

Country
Price · split & dividend adjusted
News & notes moving 301234.CS
301234.CS

Wuzhou Medical Releases 2026 Interim Report with Net Profit of 15.3634 Million Yuan

Wuzhou Medical released its 2026 interim report, with net profit attributable to the parent company of 15.3634 million yuan. The company's total operating revenue was 203 million yuan, down 6.40% from the same period last year. Net cash inflow from operating activities was 28.479 million yuan, down 43.05% year-on-year. The company's latest asset-liability ratio was 10.82%, gross margin was 18.08%, ROE was 2.01%, and diluted earnings per share was 0.23 yuan.
Jiemian·26dRead more →
301234.CS7

Wuzhou Medical's Cross-Border Chip Acquisition Sends Shares Doubling in Four Days, Valuation Risk Flagged

Wuzhou Medical's shares have seen continuous abnormal movement due to a major asset restructuring, with a cumulative deviation of 108.38 percent over four trading days. The company plans to acquire a 100 percent stake in Spintrol Electronic Technology Shanghai, crossing into the high-integration motor control chip sector, while also planning to issue shares to no more than 35 specific investors to raise supporting funds. As of July 27, the company's dynamic price-to-earnings ratio reached 148.86 times, and its static price-to-earnings ratio was as high as 253.74 times, significantly above the average for the medical consumables industry. In recent years, the company's performance has been under pressure, with revenue declining from 534 million yuan in 2023 to 458 million yuan in 2025, and net profit attributable to the parent falling from 60.2651 million yuan to 18.893 million yuan. Industry insiders note that cross-border mergers and acquisitions offer new possibilities for industry growth, but challenges such as cross-industry operational synergy cannot be overlooked.
上海证券报·54dRead more →
301234.CS

A-share weekly top movers: Wuzhou Medical surges over 70% to lead

Major A-share indexes edged slightly higher this week, but individual stocks diverged sharply. Only 1,479 stocks rose over the week, while as many as 4,007 fell. Excluding newly listed stocks this month, the top 20 gainers all posted weekly gains exceeding 25%. Among them, Wuzhou Medical soared 72.79% for the week, making it the strongest stock. Since resuming trading on July 22, the stock has hit three consecutive 20% daily limit-up moves, with its total market value rocketing from about 2.3 billion yuan before suspension to nearly 4 billion yuan. The trigger was a restructuring plan to acquire a 100% stake in Xuanzhi Electronic Technology Shanghai Company, crossing into the motor control chip sector. Lixun New Energy jumped 57.56% for the week, having previously notched seven straight limit-up days, but it suddenly broke its streak late on July 24. This week's big winners spanned sectors including pharmaceuticals, environmental protection, electronics, and power equipment. Environmental stocks such as Huicheng Environmental Protection and Tongyuan Environment rallied collectively, becoming a market highlight.
21世纪经济·56dRead more →
Robotics & Physical AI

Motor Concept Stocks Strengthen Mid-Session; Wuzhou Medical Plans to Acquire Spintrol Technology

On July 23, motor concept stocks strengthened mid-session. China Electric Motor rose 9.99%, Huayang Intelligent rose 5.75%, Zhongji Innolight rose 4.64%, Kangping Technology rose 4.21%, and Jinlong Machinery & Electronics rose 2.80%. Wuzhou Medical announced on the evening of July 21 that it plans to acquire 100% equity in Spintrol Electronic Technology (Shanghai) Co., Ltd. through a combination of share issuance and cash payment. Spintrol Technology focuses on the research, development, design, and sales of highly integrated motor control chips. According to Xinhua News Agency, Novelty Robots has made joint modules, lead screws, and ceramic balls the centerpiece of its exhibition, with its self-developed silicon nitride ceramic balls already undergoing application testing at leading robotics companies. A research report from Aijian Securities points out that the global micro and special motor market is expected to reach 53.41 billion US dollars in 2026, while the Chinese market is expected to reach 252.7 billion yuan, with a compound annual growth rate of 12.4% from 2024 to 2028. A research report from China Galaxy Securities notes that the motor industry has broad downstream applications. In the automotive electronics sector, with the rising penetration of new energy vehicles and the evolution of intelligent driving technology, the usage of micro and special motors per vehicle continues to increase, driving significant expansion in demand for automotive micro and special motors.
21世纪经济·58dRead more →